To explore the underlying downstream molecular mechanisms that VSTM2L overexpression induces resistance to CRT in cancer cells, we performed gene set enrichment analysis (GSEA) on the microarray data from GSE45404, GSE68204, GSE87211, and VSTM2L-overexpressing RNA sequence. This evidence concerns the gene VSTM2L and cancer.